Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.
about
Towards the targeted management of Chediak-Higashi syndromePharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B.Chediak-Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype.Allogeneic hematopoietic stem cell transplantation for Chediak-Higashi syndrome.
P2860
Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.
@en
Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.
@nl
type
label
Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.
@en
Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.
@nl
prefLabel
Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.
@en
Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.
@nl
P2093
P2860
P356
P1476
Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.
@en
P2093
Akira Kikuchi
Chikara Ogimi
Risa Tanaka
Ryoji Hanada
Takashi Arai
Tsutomu Oh-Ishi
P2860
P304
P356
10.1002/PBC.23231
P577
2011-06-16T00:00:00Z